Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2006-08-15
2006-08-15
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S295000, C544S317000, C544S324000, C544S328000, C514S252050, C514S252150, C514S255050
Reexamination Certificate
active
07091343
ABSTRACT:
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
REFERENCES:
patent: 2002/0052386 (2002-05-01), Armistead et al.
patent: WO 01/60816 (2001-08-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 02/50066 (2002-06-01), None
Eldar-Finkelman et al Expert Opinion on Investigational Drugs (Ashley Publications), 2003, vol. 12, No. 9, pp. 1511-1519.
Alonso M, Martinez A., Curr Med Chem. Mar. 2004;11(6):755-63.
Wagman AS, Johnson KW, Bussiere DE., Curr Pharm Des. 2004; 10(10):1105-37.
Steven L. Warner, David J. Bearss, Haiyong Han and Daniel D. Von Hoff, Molecular Cancer Therapeutics, vol. 2, 589-595, Jun. 2003.
Margaret C. Frame, Biochimica et Biophysica Acta- Reviews on Cancer, vol. 1602, Issue 2 , Jun. 21, 2002, pp. 114-130.
Bebbington David
Binch Hayley
Charrier Jean-Damien
Everitt Simon
Golec Julian M. C.
McKenzie Thomas C.
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
LandOfFree
Compositions useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617875